Skip to main content
. 2021 May 12;92(2):e2021051. doi: 10.23750/abm.v92i2.9267

Table 2.

Baseline clinical and laboratory data according to coronary artery disease

Characteristics Case (n=88) Control (n=88) P-value
Age (years) 61.07±8.42 62.50±9.15 0.281
Height 160.52±10.44 157.45±9.91 0.065
Weight 69.89±12.26 68.37±13.95 0.472
Female n (%) 44 (50.0%) 41 (46.6%) 0.651
Male n (%) 44(50.0%) 47 (53.4%)
BMI (kg/m2) 25.33±3.47 25.55±3.51 0.680
Hypertension n (%) 42(45.7%) 25(37.9%) 0.330
Diabetes n (%) 28(30.4%) 14(20.6%) 0.162
hs-CRP (mg/dl) 3.16(1.54-8.48) 2.54(0.99-6.63) 0.091
TC (mg/dl) 169.69±64.14 200.28±62.22 0.002
TG (mg/dl) 201.90±61.20 189.80±66.94 0.212
LDL-C (mg/dl) 134.10±37.02 119.86±33.85 0.008
HDL-C (mg/dl) 46.10±15.46 46.32±14.03 0.832
FBS (mg/dl) 115.49±55.35 106.66±42.67 0.279
HCT 38.64±4.50 40.37±5.50 0.011
Height/Weight 0.42±0.08 0.42±0.08 0.992
Hb 12.82±1.69 13.34±1.86 0.055
GDF-15(ng/l) 1069.58±677.46 729.40±470.36 <0.001

All values are mean ± standard deviation for quantitative normal distribution variables and median (range) for quantitative non-parametric data; also number (percentage) for Qualitative variables. BMI (body mass index), hs-CRP (high-sensitivity C reactive protein), TC (total cholesterol), TG (total triglyceride), LDL-C (low-density lipoprotein cholesterol), HDL-C (high-density lipoprotein cholesterol), FBS (fasting blood sugar), HCT (hematocrit), Height/Weight, Hb (hemoglobin) and GDF-15 (Growth Differentiation Factor-15)